Nosebleed (Epistaxis) - Posterior or Anterior Clinical Trial
Official title:
Langzeitresultate Und Komplikationen Nach Einer Epistaxisbehandlung
The aim of this study is to find the most agreeable and in the long term most efficient treatment for epistaxis.
In the general population epistaxis occurs quite frequently. Approximately 60% of persons
will be affected once in their lifetime, and 6% thereof will seek medical advice. Thereby
anterior and posterior epistaxis are discerned. Anterior epistaxis is usually located at the
Locus Kisselbachii, while posterior bleeds are found further back in the nose. There, most
bleeds will originate from the A. sphenopalatina or the A. ethmoidalis.
Different treatment modalities exist. Anterior epistaxis are usually easier to treat than
posterior ones. The aim of this study is to find the most efficient treatment. This involves
the assessment of long term results and potential sequelae. Existing data will be
complemented with information about recurrences and complications. The question is: Which
treatment method leads to the least numbers of recurrences in the long term with the fewest
long term sequelae?
Secondly, the most agreeable, least painful treatment method is to be identified. Therefore
we will send out questionnaires to patients that were treated between March 29, 2007 and
April 1st, 2008 at the Zurich University Hospital.
;
Observational Model: Cohort, Time Perspective: Prospective